• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

Comprehensive Overview of 4-Bromo-1H-pyrazole-3,5-d2 (CAS No. 95472-32-5)

4-Bromo-1H-pyrazole-3,5-d2, identified by its CAS number 95472-32-5, is a deuterated derivative of the widely studied pyrazole scaffold. This compound has garnered significant attention in pharmaceutical and agrochemical research due to its unique isotopic labeling, which enhances metabolic stability and facilitates advanced drug discovery applications. The incorporation of deuterium atoms at the 3 and 5 positions of the pyrazole ring offers distinct advantages in kinetic isotope effect studies, making it a valuable tool for mechanistic investigations and bioavailability optimization.

In recent years, the demand for deuterated compounds like 4-Bromo-1H-pyrazole-3,5-d2 has surged, driven by their pivotal role in precision medicine and next-generation therapeutics. Researchers frequently search for terms such as "deuterated pyrazole synthesis", "isotope-labeled heterocycles", and "CAS 95472-32-5 applications", reflecting the compound's relevance in cutting-edge science. Its structural features—a bromine substituent at the 4-position and deuterium atoms—enable tailored modifications for targeted drug delivery systems and proteomics research.

The synthesis of 4-Bromo-1H-pyrazole-3,5-d2 typically involves deuterium exchange reactions or labeled precursor utilization, methods that align with green chemistry principles. This aligns with the growing industry focus on sustainable synthesis and reduced environmental impact, topics frequently queried in academic and industrial forums. Analytical techniques such as NMR spectroscopy and mass spectrometry are critical for verifying the isotopic purity of this compound, ensuring its suitability for high-stakes applications like clinical trials and biomarker development.

Beyond pharmaceuticals, 4-Bromo-1H-pyrazole-3,5-d2 finds utility in material science, particularly in the design of organic electronic devices. Its ability to fine-tune molecular interactions makes it a candidate for optoelectronic materials, a hotspot in renewable energy research. Searches for "deuterated compounds in OLEDs" or "heavy atom effects in materials" underscore this interdisciplinary appeal. The compound's stability under physiological conditions also positions it as a promising probe for molecular imaging, addressing the rising demand for non-invasive diagnostic tools.

Regulatory and safety profiles of 4-Bromo-1H-pyrazole-3,5-d2 adhere to global standards for research chemicals, with emphasis on proper handling protocols. While not classified as hazardous, its use in GLP-compliant laboratories ensures data integrity—a priority for institutions investing in translational research. Frequently asked questions like "Is CAS 95472-32-5 safe for lab use?" or "Deuterated pyrazole storage guidelines" highlight the practical considerations surrounding this compound.

In summary, 4-Bromo-1H-pyrazole-3,5-d2 (CAS No. 95472-32-5) exemplifies the convergence of isotope chemistry and applied sciences. Its versatility across drug development, materials engineering, and diagnostic innovation ensures its prominence in contemporary research. As interest in deuterium-enabled technologies grows, this compound will remain a cornerstone for advancements in life sciences and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)